1. Home
  2. ABP

as 06-27-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Founded: 2004 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 15.5M IPO Year: N/A
Target Price: $4.00 AVG Volume (30 days): 5.6M
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.70 EPS Growth: N/A
52 Week Low/High: $0.15 - $11.19 Next Earning Date: 08-18-2025
Revenue: $183,000 Revenue Growth: 88.66%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: